Know Cancer

or
forgot password
  • cancer clinical trials in new mexico

  • Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care

    Albuquerque, New Mexico 87131-5636
    Acute Myeloid Leukemia
    Abatacept With Methotrexate- Phase IIB
    Local Institution
    Albuquerque, New Mexico
    Rheumatoid Arthritis
    Rollover Study Of Lapatinib In Cancer Patients
    GSK Investigational Site
    Albuquerque, New Mexico 87109
    Neoplasms, Breast, Cancer
    Study Evaluating Bazedoxifene Acetate In Osteoporosis In Postmenopausal Women
    Pfizer Investigational Site
    Santa Fe, New Mexico 87505
    Osteoporosis
    Neoadjuvant GW572016 to Treat Breast Cancer
    University of New Mexico
    Albuquerque, New Mexico 87131
    Breast Cancer
    International Immune Tolerance Study
    Ted R. Montoya Hemophilia Treatment Center
    Albuquerque, New Mexico 87131
    Hemophilia A With Inhibitors
    GALLANT 5 Tesaglitazar Versus Metformin
    Research Site
    Albuquerque, New Mexico
    Diabetes Mellitus, Type 2
    S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas
    University of New Mexico Cancer Research and Treatment Center
    Albuquerque, New Mexico 87131
    Sarcoma
    PROACT - Pre-Operative Arimidex Compared To Tamoxifen
    Research Site
    Albuquerque, New Mexico
    Breast Cancer
    Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
    University of New Mexico
    Albuquerque, New Mexico 87131
    Cancer, Breakthrough Pain
    Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough Pain
    University of New Mexico
    Albuquerque, New Mexico 87131
    Pain, Cancer, Sickle Cell Anemia, Severe Burns
    GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
    Research Site
    Albuquerque, New Mexico
    Type 2 Diabetes Mellitus
    Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies
    New Mexico Cancer Care Alliance
    Albuquerque, New Mexico 87106
    Leukemia, Lymphocytic, Acute, Leukemia, Nonlymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    Combination Paclitaxel, Carboplatin and Temozolomide
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Lung Diseases, Cancer
    Phase I Study of Capecitabine in Combination With Cisplatin and Irinotecan
    University of New Mexico
    Albuquerque, New Mexico 87131
    Solid Tumors, Cancer
    Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
    University of New Mexico
    Albuquerque, New Mexico 87131
    Corpus Uteri, Endometrial Cancer
    Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)
    University of New Mexico
    Albuquerque, New Mexico 87131
    Corpus Uteri, Endometrial Cancer
    Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Hematology Oncology Associates
    Lovelace Sandia Health Systems Dept of Hematology
    New Mexico Veterans Administration Health Care System
    Colonic Diseases, Cancer
    Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)
    University of New Mexico
    Albuquerque, New Mexico 87131
    Lung Diseases, Cancer
    Clinical Benefit of Topoisomerase Downregulation
    University of New Mexico
    Albuquerque, New Mexico 87131
    Ovarian Cancer
    Pharmacology Study of Aerosolized Liposomal
    University of New Mexico
    Albuquerque, New Mexico 87131
    Lung Diseases, Cancer
    Comparison of Aprepitant Versus Gabapentin in the Prevention of Delayed Nausea and Vomiting
    University of New Mexico
    Albuquerque, New Mexico 87131
    Cancer
    Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Prostate Cancer
    Pre-Clinical Models in Gynecological Tumors A Tissue Repository
    University of New Mexico
    Albuquerque, New Mexico 87131
    Endometrial Neoplasms, Uterine Neoplasms
    Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma
    University of New Mexico

    Trial Locations
    University of New Mexico
    New Mexico Cancer Care Associates
    Liver, Cancer
    Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
    Hematology Oncology Associates

    Trial Locations
    Hematology Oncology Associates
    Lovelace Sandia Health Systems Dept of Hematology
    St. Vincent Regional Medical Center
    Liver Cancer
    A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix
    Southwest Clinical Research
    Albuquerque, New Mexico 87102
    Uterine Cervical Dysplasia
    A Trial in Patients With Diffuse Large-B-cell Lymphoma Comparing Pixantrone Against Doxorubicin
    New Mexico Hematology/Oncology Consultants
    Albuquerque, New Mexico 87109
    Diffuse Large-Cell Lymphoma
    A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
    San Juan Oncology Association
    Farmington, New Mexico 87401
    NSCLC
    Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Stage I Lymphoepithelioma of the Nasopharynx, Stage I Squamous Cell Carcinoma of the Nasopharynx, Stage II Lymphoepithelioma of the Nasopharynx, Stage II Squamous Cell Carcinoma of the Nasopharynx, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx
    3 TPV/RTV Doses in Multiple ARV Experienced Patients - Tipranavir Dose Defining Study
    Boehringer Ingelheim Investigational Site
    Santa Fe, New Mexico
    HIV Infections
    INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
    University of New Mexico

    Trial Locations
    University of New Mexico
    Lovelace Sandia Health Systems Dept of Hematology
    Non-Hodgkin's Lymphoma, Cancer
    Phase IB Study of Gemcitabine, Docetaxel and Bevacizumab in Patients With Soft Tissue Sarcoma
    New Mexico Cancer Care Associates

    Trial Locations
    New Mexico Cancer Care Associates
    St. Vincent Regional Medical Center
    Sarcoma
    Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma
    Lovelace Sandia Health Systems Dept of Hematology

    Trial Locations
    Lovelace Sandia Health Systems Dept of Hematology
    New Mexico Cancer Care Associates
    Kidney, Cancer
    Phase I-II Study of Carboplatin, Vinorelbine and Capecitabine in Patients With Metastatic Breast Cancer
    University of New Mexico
    Albuquerque, New Mexico 87131
    Breast, Cancer
    Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung
    University of New Mexico
    Albuquerque, New Mexico 87131
    Corpus Uteri, Lung Cancer
    Pancreatic Cancer Serum and DNA Repository
    University of New Mexico
    Albuquerque, New Mexico 87131
    Pancreas Cancer
    Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
    University of New Mexico
    Albuquerque, New Mexico 87131
    Cervical Cancer, Cervix
    A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate
    Local Institution
    Albuquerque, New Mexico
    Leukemia, Myeloid, Chronic, Leukemia, Lymphocytic, Acute, L2
    Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia
    University of New Mexico Health Sciences Center

    Trial Locations
    University of New Mexico Health Sciences Center
    Cancer Institute of New Mexico
    Chronic Myeloid Leukemia
    Combination Chemotherapy With or Without Bevacizumab in Treating Patients Who Have Had Surgery for Stage II or Stage III Rectal Cancer (Groups I and II Closed to Accrual as of 4/29/2009)
    Hematology Oncology Associates

    Trial Locations
    Hematology Oncology Associates
    Presbyterian Kaseman Hospital
    New Mexico Cancer Care Associates
    Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer
    Lapatinib/Carboplatin/Paclitaxel in Previously Treated Ovarian or Breast Cancer Patients
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Ovarian Epithelial Cancer Stage III, Stage IV Ovarian Cancer, Stage IV Breast Cancer
    Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib
    University of New Mexico
    Albuquerque, New Mexico 87131
    Cholangiocarcinoma